Epigenome Editing Durability Varies Widely Across Cardiovascular Disease Target Genes
Madelynn N. Whittaker(Cardiovascular Institute of the South), Xiao Wang(Jinan University)
Cited by 2
Related Papers
Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway
|Molecular Cancer|2015|103
Verdinexor, a Selective Inhibitor of Nuclear Exportin 1, Inhibits the Proliferation and Migration of Esophageal Cancer via XPO1/c-Myc/FOSL1 Axis
|International Journal of Biological Sciences|2021|17